MedTrace Logo

Effects of Caffeine, L-Theanine, and Diaphragmatic Breathing on Esports Players' Performance

NCT06621797 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-10-01

No results posted yet for this study

Summary

The purpose of this study is to investigate whether caffeine, L-theanine (a natural amino acid found in tea), and diaphragmatic breathing exercises can help improve the game performance of esports players. Esports players often need fast reaction times, high accuracy, and mental focus during competitive gaming. This study will look at how caffeine and L-theanine supplements, either separately or together, and breathing exercises impact key performance factors like reaction time and accuracy during gameplay. The goal is to determine if these strategies can help esports players perform better by reducing stress, improving concentration, and speeding up reaction times. The findings could help inform safe, effective methods to enhance cognitive and physical performance in gaming.

Conditions

  • Esports
  • Caffeine
  • L-theanine

Interventions

DIETARY_SUPPLEMENT

Intervention 1: Dietary Supplement - Caffeine Supplement

Participants in this group will receive a caffeine supplement (3 mg/kg body weight) taken orally 45 minutes before performance testing. No additional interventions will be administered.

DIETARY_SUPPLEMENT

Intervention 2: Dietary Supplement - Caffeine + L-Theanine Supplement

Participants in this group will receive a caffeine supplement (3 mg/kg body weight) along with L-theanine in a 1:2 ratio taken orally 45 minutes before performance testing.

BEHAVIORAL

Intervention 3: Dietary Supplement - Caffeine Supplement + Diaphragmatic Breathing Exercises

Participants in this group will receive a caffeine supplement (3 mg/kg body weight) 45 minutes before performance testing, followed by a 10-minute session of diaphragmatic breathing exercises.

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-09-24
Completion
2024-09-26

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06621797 on ClinicalTrials.gov